No Cover Image

Journal article 869 views 353 downloads

Cardiovascular safety of liraglutide for the treatment of Type 2 diabetes

RA Chudleigh, Steve Bain Orcid Logo

Expert Opinion on Drug Safety

Swansea University Author: Steve Bain Orcid Logo

Check full text

DOI (Published version): 10.1080/14740338.2017.1313225

Published in: Expert Opinion on Drug Safety
ISSN: 1474-0338 1744-764X
Published: 2017
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa32907
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2017-04-03T13:05:46Z
last_indexed 2018-02-09T05:21:20Z
id cronfa32907
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2017-04-10T16:41:44.9698050</datestamp><bib-version>v2</bib-version><id>32907</id><entry>2017-04-03</entry><title>Cardiovascular safety of liraglutide for the treatment of Type 2 diabetes</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2017-04-03</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Expert Opinion on Drug Safety</journal><publisher/><issnPrint>1474-0338</issnPrint><issnElectronic>1744-764X</issnElectronic><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2017</publishedYear><publishedDate>2017-12-31</publishedDate><doi>10.1080/14740338.2017.1313225</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2017-04-10T16:41:44.9698050</lastEdited><Created>2017-04-03T09:09:38.7368039</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>RA</firstname><surname>Chudleigh</surname><order>1</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>2</order></author></authors><documents><document><filename>0032907-03042017091125.pdf</filename><originalFilename>Chudleigh2017.pdf</originalFilename><uploaded>2017-04-03T09:11:25.2230000</uploaded><type>Output</type><contentLength>660165</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2018-04-07T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling 2017-04-10T16:41:44.9698050 v2 32907 2017-04-03 Cardiovascular safety of liraglutide for the treatment of Type 2 diabetes 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2017-04-03 BMS Journal Article Expert Opinion on Drug Safety 1474-0338 1744-764X 31 12 2017 2017-12-31 10.1080/14740338.2017.1313225 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2017-04-10T16:41:44.9698050 2017-04-03T09:09:38.7368039 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine RA Chudleigh 1 Steve Bain 0000-0001-8519-4964 2 0032907-03042017091125.pdf Chudleigh2017.pdf 2017-04-03T09:11:25.2230000 Output 660165 application/pdf Accepted Manuscript true 2018-04-07T00:00:00.0000000 true eng
title Cardiovascular safety of liraglutide for the treatment of Type 2 diabetes
spellingShingle Cardiovascular safety of liraglutide for the treatment of Type 2 diabetes
Steve Bain
title_short Cardiovascular safety of liraglutide for the treatment of Type 2 diabetes
title_full Cardiovascular safety of liraglutide for the treatment of Type 2 diabetes
title_fullStr Cardiovascular safety of liraglutide for the treatment of Type 2 diabetes
title_full_unstemmed Cardiovascular safety of liraglutide for the treatment of Type 2 diabetes
title_sort Cardiovascular safety of liraglutide for the treatment of Type 2 diabetes
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
author Steve Bain
author2 RA Chudleigh
Steve Bain
format Journal article
container_title Expert Opinion on Drug Safety
publishDate 2017
institution Swansea University
issn 1474-0338
1744-764X
doi_str_mv 10.1080/14740338.2017.1313225
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2017-12-31T03:40:29Z
_version_ 1763751838633426944
score 11.012678

Similar Items